All three tenses have at least two readings, so the archetype blend applies as printed.
All nine metrics read as filed from the record.
What did they actually do?
Has it survived what it has been through?
2 warning events since 2017; the latest 2021-03-03.
From the record
Labcorp Holdings Inc.'s filings since 2017 show 2 warning events: an auditor change (8-K item 4.01, 2 times, the latest 2021-03-03) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+4.3% a year over 10 filed years; profitable in 10 of 10.
From the record
Labcorp Holdings Inc.'s 10 filed years say what it did: revenue went from $9.6 billion in fiscal 2016 to $14 billion in fiscal 2025, up 4.3% a year; it rose in 7 of 9 years; the deepest fall was 15% from fiscal 2020 to fiscal 2022; net income was positive in 10 of 10 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
Share count shrank 2.9% a year. 54% of cash flow returned. Insiders: 22 sales, 0 purchases.
From the record
Over the 3 fiscal years to 2025-12-31, Labcorp Holdings Inc.'s diluted share count shrank about 2.9% a year, and dividends and buybacks returned about 54% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 22 sales (14 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-12 (their Form 4 filings).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they doing right now?
Is it financially healthy right now?
ROE 10%: 10¢ of profit per shareholder dollar. Leverage 53%: owes 53¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-12-31, Labcorp Holdings Inc. earned about 10 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 22 cents per dollar of everything the company owns. Leverage: it owed about 53 cents per dollar of assets, and net share issuance: its share count shrank 0.7% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
top 29% of 24 in its family; net margin 6.3%.
From the record
Labcorp Holdings Inc.'s standing among 24 graded names in its industry family: revenue of $14 billion in fiscal 2025 ranks in the top 2% by size; a net margin of 6.3% ranks in the top 15%; revenue growth of 5.6% a year over the last 3 filed years ranks in the bottom 28% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
top 42% of 17 in its family for leadership; chief executive since 2019.
From the record
Labcorp Holdings Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Schechter, Adam H (President & CEO, as filed), filing under that title since 2019-11-05, 7 years (top 26% of its family); the 23 officers and directors filing in the last fifteen months have been on the record a median of 5.6 years (top 43%); 7 officer or director changes were reported on Form 8-K since 2023-11-13, against the 23 people in charge now (bottom 43%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they set up to do next?
How much room does it have to grow?
bottom 50% of 24 in its family for room to expand.
From the record
Labcorp Holdings Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $532 million against debt of $5.1 billion leaves -24.8% of its assets as net cash, bottom 21% of its family; cash from operations less capital spending is 8.6% of revenue (top 19%); a gross margin of 28.8% (bottom 47%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
top 49% of 23 in its family for growth drivers.
From the record
Labcorp Holdings Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 5.6% a year over the last three filed years against 4.3% over all 10, speeding up (top 33% of its family); the newest year grew 7.3% (bottom 37%); capital spending grew 0.4% a year (top 50%) (its annual reports). Labcorp Holdings Inc. reported 2 lines of business in fiscal 2025: Diagnostics at $11 billion, Biopharma Laboratory Services at $3.1 billion. 2 of 2 grew in the latest filed year, and the largest line is 78% of revenue (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
bottom 41% of 20 in its family for expectations against reality.
From the record
Labcorp Holdings Inc.'s newest year against its own record: revenue of $14 billion in fiscal 2025 came in 2.4% above the $14 billion its prior three years' pace pointed to (top 42% of its family); net income of $877 million against a prior three-year average of $814 million (bottom 33%); a net margin of 6.3% against 6.7% before (bottom 33%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made